Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Filings indexed 1,118 across all filing types
Latest filing 2024-09-23 Board/Management Inform…
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Trading Window
Board/Management Information Classification · 95% confidence The document is a notice from Unichem Laboratories Limited addressed to stock exchanges regarding the closure of the trading window for insiders and designated persons. It references an upcoming Board Meeting scheduled to consider business integration matters and states the trading window closure period around the announcement of quarterly and half-year financial results. The document is short (1926 characters) and serves as an announcement about the Board Meeting and trading restrictions, not the financial results or detailed report itself. It does not contain financial data or detailed report content. Therefore, it is an announcement related to Board/Management Information, specifically about the Board Meeting and insider trading window closure, which falls under Board/Management Information (MANG).
2024-09-23 English
Trading window shall be closed from 23.09.2024 to till 48 Hrs after declaration of financial results and other matters.
Regulatory Filings
2024-09-23 English
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2024 ,inter alia, to consider and approve integration and consolidation ....
Regulatory Filings
2024-09-23 English
Board Meeting — Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice from Unichem Laboratories Limited addressed to stock exchanges regarding the closure of the trading window for insiders ahead of a Board Meeting scheduled for 30th September 2024. It mentions the trading window closure in relation to the upcoming financial results announcement for the quarter and half year ended 30th September 2024. The document does not contain any financial data or results itself, nor does it present a report. It is a regulatory announcement about insider trading restrictions and the scheduling of a Board Meeting. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-09-23 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding an update on a USFDA inspection classification for the company's facility. It references a prior intimation and provides regulatory disclosure under SEBI Listing Obligations. There is no financial data, no detailed report, no voting results, no management discussion, or other substantive report content. The document is an announcement of a regulatory event and is brief (1171 characters). Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-10 English
Intimation under Regulation 30 of SEBI LODR
Regulatory Filings
2024-09-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.